Results 251 to 260 of about 91,972 (285)

A Rational Approach to Total Thymectomy in the Treatment of Myasthenia Gravis

open access: bronze, 1977
Alfred Jaretzki   +6 more
openalex   +1 more source

Myasthenia gravis

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1986
openaire   +2 more sources

Reply to Tellez-Zenteno [PDF]

open access: yes, 2017
Roth, Thierry Christophe   +1 more
core  
Some of the next articles are maybe not open access.

Related searches:

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.

NEJM Evidence, 2022
Ravulizumab in Generalized Myasthenia GravisIn this randomized controlled trial, ravulizumab provided rapid and efficacious treatment of adult patients with anti-acetylcholine reception antibody-positive generalized myasthenia gravis, as determined by ...
Tuan Vu   +9 more
semanticscholar   +1 more source

Myasthenia Gravis

New England Journal of Medicine, 2016
Myasthenia gravis is an autoimmune disease, which leads to load-dependent weakness of voluntary skeletal muscles with recovery of function after resting. The disease is caused by autoantibodies directed against the postsynaptic nicotinic acetylcholine receptors (AChR) leading to a reduction of neuromuscular transmission.
PRIOLA, adriano massimiliano   +2 more
openaire   +9 more sources

Myasthenia Gravis

Seminars in Neurology, 1990
The treatment of patients with myasthenia gravis should be individualized according to the extent (ocular versus generalized) and severity (mild to severe) of disease, the presence or absence of concomitant disease (including but not limited to other autoimmune diseases and thymoma), and, to a lesser degree, the age of the patient. Thymectomy should be
D M, Linton, D, Philcox
openaire   +5 more sources

Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis

European Journal of Neurology, 2021
Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma recurrence or unresectable lesions entail a worse prognosis of MG.
R. Álvarez-Velasco   +29 more
semanticscholar   +1 more source

Myasthenia Gravis

2013
Myasthenia gravis (MG) is a rare autoimmune disease with dysfunction of the postsynaptic transmission at the motor endplate. The early fatigue of muscle strength that varies depending on the time of day is a typical sign of MG. It is unclear, if intensive muscle training can induce early fatigue of muscle strength and lead to an exacerbation of ...
Konstantinos Lazaridis, Socrates Tzartos
openaire   +4 more sources

Home - About - Disclaimer - Privacy